Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1060450]Researchers: Prof Mark Cooper (Principal investigator) , Dr Zhonglin Chai
Brief description We have validated CDA1 as an effective target to retard kidney disease in diabetes using a mouse model where we deleted the CDA1gene. We have also developed a novel agent to inhibit CDA1 in order to retard diabetic kidney disease. In this application, we propose to confirm the efficacy of targeting CDA1 using various diabetes models and a range of strategies to target CDA1. We will also rigorously explore translation of these findings to a new treatment for diabetic renal disease.
Funding Amount $AUD 663,050.39
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1060450
- PURL : https://purl.org/au-research/grants/nhmrc/1060450